Pages

Showing posts with label Ireland. Show all posts
Showing posts with label Ireland. Show all posts

Saturday, 30 January 2021

EU vaccine export row: Bloc backtracks on controls for NI

The EU has reversed its decision to temporarily override part of the Brexit deal amid an ongoing row over Covid vaccine supplies in the bloc.

16 minutes ago
Related Topics
Vaccines behind EU flag (file image)IMAGE COPYRIGHTREUTERS

The EU has reversed its decision to temporarily override part of the Brexit deal amid an ongoing row over Covid vaccine supplies in the bloc.

The move would have seen checks at the border of Ireland and Northern Ireland to prevent shipments entering the UK.

But the European Commission later said it would ensure the Northern Ireland Protocol is "unaffected".

Boris Johnson had expressed "grave concerns" about the plan in a phone call with the commission's president.

President Ursula von der Leyen later tweeted to say she had held "constructive talks" with the prime minister.

She said they had "agreed on the principle that there should not be restrictions on the export of vaccines by companies where they are fulfilling contractual responsibilities".

The EC proposals had also sparked concern from all five parties in Northern Ireland's devolved government and Irish prime minister Micheál Martin.

Mr Martin welcomed the EU's reversal, describing it as a "positive development given the many challenges we face in tackling Covid-19".

However, it was not thought that the move would have directly disadvantaged Northern Ireland, which gets its vaccine supplies through the UK procurement system.

'Actions justified'

The Brexit deal guarantees an open border between the EU and Northern Ireland, with no controls on exported products.

However, Article 16 of the Northern Ireland Protocol part of the deal allows the EU and UK to chose to suspend any aspects they consider are causing "economic, societal or environmental difficulties".

The EU had announced it would trigger the clause and introduce the export controls on its vaccines entering Northern Ireland in a bid to prevent the region becoming a backdoor for jabs to be sent to the wider UK.

2px presentational grey line
Analysis box by Katya Adler, Europe editor

"Mistake," "misjudgement," "blunder."

These are just some of words EU insiders have been using privately to describe the European Commission's initial decision on Friday to suspend areas of the Brexit deal dealing with Northern Ireland, a part of its Covid vaccine row.

Although it then U-turned on those plans, critics say the damage was already done.

Brussels previously lectured the UK government about respecting the Irish Protocol - which was painfully and carefully drafted during Brexit negotiations.

Now the EU seemed quick to undermine the agreement.

Member state Ireland felt stung that it hadn't been consulted. This all adds to the impression of chaos surrounding the EU's vaccine rollout.

Brussels was already under fire from a growing number of EU countries for having been slow to sign vaccine contracts with pharmaceutical companies.

This "mishap" over the Irish Protocol as Spain's Foreign Minister called it, hasn't exactly helped the commission's reputation.

2px presentational grey line

Despite backtracking on Article 16, the EU is still introducing new controls giving its member states the power to block exports of the coronavirus vaccine to countries including the UK - should they want to.

The move was the latest development in a deepening dispute over the vaccine producer AstraZeneca's delivery commitments to the EU.

European Commission President Ursula von der LeyenIMAGE COPYRIGHTPA MEDIA
image captionEuropean Commission President Ursula von der Leyen said talks between her and Boris Johnson had been "constructive"

The bloc agreed to buy up to 400m doses of the vaccine AstraZeneca developed last year with Oxford University, and on Friday the EU's drugs regulator approved the vaccine's use for all adults.

But the firm said that due to problems at one of its EU factories, supplies would be reduced by about 60% in the first quarter of 2021.

The statement from the European Commission said it in order to tackle "the current lack of transparency" over vaccine exports outside the EU, it would be introducing a measure requiring that all such exports "are subject to an authorisation" by member states.

While the commission rowed back from the Article 16 threat, the EU warned that it would "consider using all the instruments at its disposal" should vaccine supplies "toward third countries be abused to circumvent the effects of the authorisation system".

'Profound misjudgement'

The EU's original move was criticised by a string of politicians, with Northern Ireland's First Minister Arlene Foster describing it as "an incredible act of hostility" that places a "hard border" between Northern Ireland and the Republic of Ireland.

In a phone call earlier with the Irish Taoiseach Mr Martin on Friday evening, Mr Johnson "set out his concerns" about the move and "what these actions may mean for the two communities in Northern Ireland", according to a No 10 spokesperson.

media captionArlene Foster: EU Covid vaccine controls are an "act of aggression"

The PM is also said to have "stressed the UK's enduring commitment" to the Good Friday agreement and called on the EU to "urgently clarify its intentions and what steps it plans to take to ensure its own commitments with regards to Northern Ireland are fully honoured".

Banner image reading 'more about coronavirus'
Banner

Ireland's foreign minister Simon Coveney welcomed the EU's reversal, but said "lessons should be learned".

"The Protocol is not something to be tampered with lightly, it's an essential, hard-won compromise, protecting peace and trade for many," he tweeted.

Labour's Louise Haigh, the shadow Northern Ireland secretary, said the EU's "profound misjudgement" had caused "unnecessary damage and set back efforts to make the Protocol work".

Meanwhile, in an interview with the Times, Michel Barnier, who was the EU's chief Brexit negotiator, called for "co-operation" between the EU and the UK over the vaccine supplies across Europe.

He said the world was facing an "extraordinarily serious crisis" which he argued must be faced with "responsibility" rather than the "spirit oneupmanship or unhealthy competition".

He added: "I recommend preserving the spirit of co-operation between us."


https://www.bbc.com/news/uk-55865539

Thursday, 31 December 2020

The EU’s AstraZeneca vaccine dispute and U-turn explained

 The European Union has retreated from a plan to override part of the Brexit deal on Northern Ireland over export controls on coronavirus vaccines.

 31 January 2021

© Peter Byrne NHS staff prepare to administer a Oxford/AstraZeneca Covid-19 vaccine (Peter Byrne/PA)

But following widespread condemnation of the move, the EU is facing further criticism over its decision to push ahead with imposing controls on vaccines manufactured within member states.

It comes amid a bitter row between the bloc and AstraZeneca over shortfalls in delivery of the pharmaceutical company’s Covid-19 vaccine, which was authorised for use in adults throughout the EU on Friday.

Here, the PA news agency looks at the U-turn and how the row has unfolded.

– What prompted the political uproar?

On Friday, Brussels announced it would invoke Article 16 of the Northern Ireland Protocol to stop the country being used as a back door to move coronavirus vaccines from the bloc into the UK.

The EU later reversed the move following condemnation from London, Dublin and Belfast.

–  Why did the EU announce the plan?

The NI Protocol, which is part of the Withdrawal Agreement, is designed to allow the free movement of goods from the EU into Northern Ireland, preventing the need for a hard border on the island of Ireland.

But triggering Article 16 would have temporarily placed export controls on the movement of vaccines as the EU moves to protect its own supplies.

– And why did it make a U-turn?

The protocol move provoked condemnation from both sides of the Irish border – with Northern Ireland’s First Minister Arlene Foster calling it an “incredible act of hostility”.

Boris Johnson expressed “grave concerns” to European Commission president Ursula von der Leyen and also discussed the issue with Irish premier Micheal Martin, who reportedly was not given advance notice of Brussels’ decision.

The European Commission then reversed the decision and announced it was “not triggering the safeguard clause” to ensure the protocol is “unaffected”.

– Why does the EU have issues with its vaccine supplies?

AstraZeneca has said initial deliveries to the EU will fall short because of a production glitch – said to be at a hub in Belgium – and it will not be able to meet its supply targets for the first three months of this year.

The British-Swedish company announced initial deliveries in the EU would total approximately 31 million doses – rather than the anticipated 80 million in the first quarter.

With the speed of the UK’s vaccine rollout outstripping other European countries, the EU has suggested doses produced in Britain should be directed elsewhere to make up the shortfall.

Ms von der Leyen has called for an explanation from AstraZeneca for delivery hold-ups, as she insisted the supply orders are “binding” and “the contract is crystal clear”.

– Has AstraZeneca responded?

In an interview with Italy’s la Repubblica newspaper, AstraZeneca chief executive Pascal Soriot had said the contract only committed to meet the EU’s demands to its “best effort”.

He said the EU’s deliveries were delayed in part because the bloc signed its contract later than the UK, and therefore EU manufacturing facilities were still catching up.

AstraZeneca and its partner Oxford University signed a deal with the UK Government for 100 million doses three months before the EU deal for 400 million doses was agreed, according to Mr Soriot.

– What else has the EU said?

On Friday, the European Commission tightened the rules on the export of vaccine doses produced in the 27 EU countries.

The “vaccine export transparency mechanism″ will be used until the end of March to control vaccine shipments to non-EU countries, with any exporting company required to submit its plans to national authorities.

Officials have insisted the measure is not an export ban and that the move is intended to ensure member nations receive doses they bought from vaccine producers.

– Could the UK’s vaccine supply be affected?

These controls could hinder the UK’s access to further supplies, particularly to the Belgian-made Pfizer jab, which the UK is scheduled to get 3.5 million doses of over the next three weeks.

Meanwhile, the majority of the UK’s AstraZeneca/Oxford vaccine supply is manufactured in the UK rather than at the firm’s Belgium plant, so it is not expected to be disrupted by the row.

– How many doses of vaccine has the UK ordered?

The UK Government has so far secured 40 million doses of the BioNTech/Pfizer vaccine and 100 million of the Oxford/AstraZeneca jab.

© Provided by PA Media (PA Graphics)

It has also ordered 17 million from Moderna, the most recently approved vaccine, although supplies are not expected to arrive until spring.

The UK has also secured 60 million doses of the Novavax jab with the hope that the Medicines and Healthcare products Regulatory Agency will approve it for use within weeks.

– How is the rollout progressing in the UK?

Government data shows more than 7.8 million people in the UK have received a first dose of either the Pfizer or AstraZeneca vaccine.

https://www.msn.com/en-gb/news/uknews/the-eus-astrazeneca-vaccine-dispute-and-u-turn-explained/ar-BB1deoay?li=AAnZ9Ug